Sort by
Medicine and Dentistry
Breast Cancer
100%
Breast Cancer Cell Line
25%
Cancer Cell
50%
Cancer Cell Line
50%
Cancer Types
25%
Cell Line
100%
Cellular Model
25%
Chemosensitivity
75%
Cisplatin
25%
Clustered Regularly Interspaced Short Palindromic Repeat
25%
CRISPR Associated Protein
75%
Decitabine
75%
Demethylation
25%
DNA Damage Response
100%
Downregulation
25%
Epirubicin
25%
Immunocompetent Cell
25%
In Vitro
50%
Interferon
50%
Methylation
75%
Neoplasm
25%
Olaparib
25%
Promoter Region
75%
Upregulation
25%
Immunology and Microbiology
Breast Cancer Cell Line
25%
Cancer Cell
50%
Cancer Cell Line
50%
Cell Line
100%
Chemosensitivity
75%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Coculture
25%
Demethylation
25%
DNA Damage Response
100%
Downregulation
25%
Drug Concentration
25%
Immunocompetent Cell
25%
interferon
50%
Methylation
75%
Promoter Region
75%
Upregulation
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Chemosensitivity
60%
Cisplatin
20%
Coculture
20%
CRISPR
80%
Decitabine
60%
Demethylation
20%
DNA Damage Response
100%
Downregulation
20%
Drug Concentration
20%
Epirubicin
20%
Immunocompetent Cell
20%
Interferon
40%
Methylation
60%
Promoter Region
60%
Upregulation
20%
Keyphrases
5-aza-2′-deoxycytidine
4%
Antitumor Immune Response
4%
Breast Cancer
100%
Breast Cancer Cell Lines
4%
Breast Cancer Cells
9%
BT-549 Cells
4%
BT549
4%
Cancer Cell Lines
9%
Cancer Types
4%
Cellular Models
4%
Chemosensitivity
14%
Cisplatin
4%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
4%
CRISPR-associated Protein 9
14%
Decitabine
9%
Demethylation
4%
DNA Damage
14%
DNA Damage Response
100%
Drug Concentration
4%
Epirubicin
4%
Family Members
100%
Genomic Determinants
4%
High Sensitivity
4%
Immune Cells
4%
Improved Outcomes
4%
In Vitro Effect
4%
Indirect Coculture
4%
Interferon-α (IFN-α)
4%
MDA-MB-231
4%
Mechanism of Action
4%
Methylation
9%
Modified Cells
4%
Multiple Cell Lines
4%
Non-lethal
4%
Olaparib
4%
Personalized Approach
4%
Promoter Methylation
4%
Promoter Region
4%
Refractory Cancer
4%
Response Sensitivity
4%
RNA Sequencing (RNA-seq)
4%
Schlafen
100%
Stimulator of Interferon Genes (STING)
4%
T47D
4%
T47D Cells
4%
Targeted Therapy
4%
Transcriptomics
4%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Cisplatin
20%
CRISPR Associated Protein
60%
Decitabine
60%
Drug Concentration
20%
Epirubicin
20%
Interferon
40%
Neoplasm
20%
Olaparib
20%